Endpoints News· Max Gelman·· 2 小时前AI 评分42
FDA 对 Bright Minds 实验性癫痫药物实施部分临床暂停，股价大跌
FDA puts Bright Minds drug on partial hold, stock tanks
AI 导读
FDA 对 Bright Minds Biosciences 的一款实验性癫痫药物实施部分临床暂停，公司于周一宣布该消息。监管机构未在可获取的正文中披露暂停的具体原因，消息公布后公司股价大跌。
正文 · 原文
The FDA placed an experimental seizure drug from Bright Minds Biosciences on a partial clinical hold, the company announced Monday.
Regulators issued the hold for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源：Endpoints News · endpoints.news